Quarterly report pursuant to Section 13 or 15(d)

3. Equity (Details Narrative)

v3.20.2
3. Equity (Details Narrative) - USD ($)
 2 Months Ended 3 Months Ended 5 Months Ended 6 Months Ended
Mar. 12, 2020
Apr. 06, 2020
Jun. 12, 2020
Jun. 30, 2020
Jun. 30, 2019
Share-based compensation expense       $ 565,433 $ 113,861
Options [Member]          
Share-based compensation expense       $ 565,433 $ 91,431
Options granted       486,236  
Option exercise price       $ 2.31  
Unrecognized compensation expense       $ 3,092,935  
Aggregate intrinsic value options vested       638,679  
Aggregate intrinsic value options exercisable       638,679  
Options [Member] | One Employee and Two Consultants [Member]          
Options granted 175,000        
Vesting term 4 years        
Option exercise price $ 2.21        
Fair value of options granted $ 337,691        
Options [Member] | One Employee [Member]          
Options granted   125,000      
Vesting term   4 years      
Option expiration period   10 years      
Option exercise price   $ 2.20      
Fair value of options granted   $ 242,151      
Options [Member] | Four Directors [Member]          
Options granted     46,559    
Vesting term     1 year    
Option expiration period     10 years    
Option exercise price     $ 2.47    
Fair value of options granted     $ 399,991    
Warrants [Member]          
Share-based compensation expense       76,262  
Aggregate intrinsic value of warrants vested and exercisable       $ 2,582,083  
2017 Stock Plan [Member]          
Shares authorized under plan       2,000,000  
Shares remaining for issuance       0  
2020 Stock Plan [Member]          
Shares authorized under plan       3,000,000  
Shares remaining for issuance       2,749,264